Saint-Colomban, France

Karine Descroix

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Ase & Bio. Active years: 2013.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karine Descroix: Innovator in Immunology

Introduction

Karine Descroix is a notable inventor based in Saint-Colomban, France. She has made significant contributions to the field of immunology through her innovative research and patenting efforts. Her work focuses on the use of modified oligo-β-(1,3)-glucans for treating various diseases of the immune system.

Latest Patents

Karine Descroix holds a patent for the "Use of modified oligo-β-(1,3)-glucans for treating diseases of the immune system, oligo-β-(1,3)-glucan-(1,3)-mannose, oligo-β-(1,3)-glucan-(1,3)-mannitol and derivatives thereof, methods for preparing them and medicaments containing them." This invention relates to the use of specific compounds for preparing medicaments aimed at treating diseases such as tumors, cancer, viral diseases, bacterial diseases, fungal diseases, and autoimmune diseases in both humans and warm-blooded animals. The patent also covers new products with mannose or mannitol terminations and methods for their preparation.

Career Highlights

Throughout her career, Karine has worked with various companies, including Ase & Bio and Laboratoires Goemar. Her experience in these organizations has allowed her to develop her expertise in immunology and contribute to advancements in medical treatments.

Collaborations

Karine has collaborated with notable professionals in her field, including Jean-Claude Yvin and Frank Jamois. These partnerships have further enriched her research and innovation efforts.

Conclusion

Karine Descroix is a pioneering inventor whose work in immunology has the potential to impact the treatment of various diseases significantly. Her dedication to research and innovation continues to inspire advancements in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…